Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE2/PHASE3
INTERVENTIONAL
2006-08-31
2008-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Electronic Multimedia Discharge Application
NCT02752321
Feasibility of a Goal-based Agenda Setting Intervention
NCT04696484
Integrated Telemedicine Program Evaluation
NCT07042477
MORE-PC: A 30-day Automated SMS Program to Support Post-discharge Transitions of Care
NCT05245773
Discharge Follow-up Phone Call Program
NCT03050918
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Timely Discharge (Remote Presence Technology)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primary care physicians in internal medicine
* Primary care physicians/practice group with established discharge pattern after 11 am
* Primary care physicians/practice group with fast access digital subscriber line (DSL) 300 kilobytes per second
* Primary care physicians/practice group who have Hackensack Medical Center (HUMC) intranet access from pre-determined location
Exclusion Criteria
* Patients requiring acute level of care on the day of discharge
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hackensack Meridian Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joseph Feldman, MD
Role: PRINCIPAL_INVESTIGATOR
Hackensack Meridian Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hackensack University Medical Center
Hackensack, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Intouch Technologies Inc
Identifier Type: -
Identifier Source: secondary_id
Horizon Blue Cross Blue Shield
Identifier Type: -
Identifier Source: secondary_id
06.01.052
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.